Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open Trial of Relapse Prevention Therapy for Smokers With Schizophrenia

NCT01576640 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.

NCT NCT01576640
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01576640 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open Trial of Relapse Prevention Therapy for Smokers With Schizophrenia
Lead sponsor
Massachusetts General Hospital
Phase
Phase 4
Overall status
Terminated
Start date
December 31, 2005
Completion date
October 31, 2007
Enrollment
17 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

nicotine dependence, schizophrenia